Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Enliven Therapeutics, Inc. (IMRA)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18
   10-K10-KS-1/A
Net income  -41.4-23.5-11.3
Depreciation and amortization   [+]0.10.0 
Stock-based compensation  2.20.90.6
Change in working capital   [+]2.02.21.2
Other operating activities  -0.4-1.50.8
Cash from operations  -37.4-21.9-8.8
   
Capital expenditures  0.0-0.10.0
Purchases of short-term investments, net  -16.7-23.9 
Cash from investing  -16.7-24.10.0
   
Issuance of common stock, net  80.4  
Option exercises  1.0  
Other cash from financing  17.543.66.5
Cash from financing  96.943.66.5
   
Free cash flow  -37.4-22.0-8.8
        Per share (diluted)  ($2.69)($31.34)($0.01)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy